OmniSonics, Boston work on stroke tech together
This article was originally published in Clinica
Vascular disease firm OmniSonics Medical Technologies (Wilmington, Massachusetts) is set to jointly develop its OmniWave technology alongside Boston Scientific for an application in the treatment of acute ischaemic stroke. The OmniWave product is designed to deliver low-power ultrasonic energy to remove a blood clot. Funding of the project, based on the achievement of certain development milestones, will come from Boston, which also has the option to acquire the resulting technology and the exclusive rights to the intellectual property covering the treatment of acute stroke. Other financial details of the licensing and development agreement were not disclosed.